Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

2 results
12:00 AM, Jul 31, 2014  |  BC Innovations | Targets & Mechanisms

Neo enough in glioma

Agenus Inc. Agenus' Oncophage vaccine-first developed by Srivastava-contains heat shock 90 kDa protein b1 ( Hsp90B1
GP96 ; GRP94 ) and associated peptides purified from autologous tumor cells. Oncophage is marketed …
12:00 AM, Jun 11, 2009  |  BC Innovations | Targets & Mechanisms

Poison pen letters

survival in kidney cancer patients receiving the company's Oncophage vitespen. Oncophage uses heat shock protein GP96
described the RNAi vaccination method as less direct than vaccinating with tumor-associated proteins such as GP96
Antigenics. Parsa noted that Oncophage is aided by the presence of specific receptors for tumor-derived GP96